Campomanes, Angelly R.
HRN: 10-53-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2022
CEFTRIAXONE 1G (VIAL)
06/27/2022
06/27/2022
IVT
2g
On Call To OR
Pre-op Prophylaxis For Pelvic Lap
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes